- E-mailingeborg.bronstad@uib.no
- Visitor AddressHaukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst5009 Bergen
- Postal AddressPostboks 78045020 Bergen
Academic article
- (2019). Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome. Nutrients. 1-13.
- (2018). Fecal fat and energy loss in pancreas exocrine insufficiency: the role of pancreas enzyme replacement therapy. Scandinavian Journal of Gastroenterology. 1132-1138.
- (2018). Assay of steroids by liquid chromatography-tandem mass spectrometry in monitoring 21-hydroxylase deficiency. Endocrine Connections. 1542-1550.
- (2017). Prolonged intestinal transit and diarrhea in patients with an activating GUCY2C mutation. PLOS ONE.
- (2014). Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. Endocrine Connections. 67-74.
- (2014). CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles. European Journal of Endocrinology (EJE). 743-750.
Academic lecture
- (2021). Kort- og langtidseffekten av lav FODMAP-dietten på symptomer og kortkjedede fettsyrer hos pasienter med irritabel tarmsyndrom.
- (2020). Short and extended effects of a low FODMAP diet on symptoms and short-chained fatty acids in patients with irritable bowel syndrome.
Abstract
- (2022). Bergen Braingut Study: Relations between fecal microbiota profile and its metabolites (short-chain fatty acids) and symptoms in irritable bowel syndrome. United European Gastroenterology journal. 412-412.
- (2013). Characterisation of the CYP21A2 Gene in Patients with Autoimmune Addison's Disease. Scandinavian Journal of Immunology. 310-310.
More information in national current research information system (CRIStin)